12/4
01:58 pm
alvo
Alvotech (ALVO): A Bull Case Theory [Yahoo! Finance]
Low
Report
Alvotech (ALVO): A Bull Case Theory [Yahoo! Finance]
12/4
01:20 pm
alvo
Rosen Law Firm Encourages Alvotech Investors to Inquire About Securities Class Action Investigation – ALVO
Low
Report
Rosen Law Firm Encourages Alvotech Investors to Inquire About Securities Class Action Investigation – ALVO
12/3
08:04 am
alvo
Alvotech (NASDAQ:ALVO) was given a new $10.00 price target on by analysts at Morgan Stanley.
Low
Report
Alvotech (NASDAQ:ALVO) was given a new $10.00 price target on by analysts at Morgan Stanley.
12/2
08:10 pm
alvo
Alvotech (ALVO) Faces Investor Scrutiny Amid Manufacturing Deficiencies Severely Impacting Assurances of 2025 Revenues and Adjusted EBITDA, Stock Tumbles 33% -- Hagens Berman
Low
Report
Alvotech (ALVO) Faces Investor Scrutiny Amid Manufacturing Deficiencies Severely Impacting Assurances of 2025 Revenues and Adjusted EBITDA, Stock Tumbles 33% -- Hagens Berman
11/24
08:06 pm
alvo
Alvotech (ALVO) Q3 2025 Earnings Call Highlights: Strong Revenue Growth Amid Regulatory Challenges [Yahoo! Finance]
Low
Report
Alvotech (ALVO) Q3 2025 Earnings Call Highlights: Strong Revenue Growth Amid Regulatory Challenges [Yahoo! Finance]
11/24
12:43 pm
alvo
Alvotech (ALVO) Faces Investor Scrutiny Amid Manufacturing Deficiencies Severely Impacting Assurances of 2025 Revenues and Adjusted EBITDA, Stock Tumbles 33% -- Hagens Berman
Low
Report
Alvotech (ALVO) Faces Investor Scrutiny Amid Manufacturing Deficiencies Severely Impacting Assurances of 2025 Revenues and Adjusted EBITDA, Stock Tumbles 33% -- Hagens Berman
11/24
05:30 am
alvo
Alvotech Announces Approval of AVT03, a Biosimilar to Prolia® and Xgeva® (denosumab) in the European Economic Area
Medium
Report
Alvotech Announces Approval of AVT03, a Biosimilar to Prolia® and Xgeva® (denosumab) in the European Economic Area
11/22
07:56 am
alvo
Alvotech (NASDAQ:ALVO) was downgraded by analysts at Zacks Research from a "hold" rating to a "strong sell" rating.
Medium
Report
Alvotech (NASDAQ:ALVO) was downgraded by analysts at Zacks Research from a "hold" rating to a "strong sell" rating.
11/22
02:11 am
alvo
Medium
Report
11/20
10:00 am
alvo
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Alvotech - ALVO
Medium
Report
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Alvotech - ALVO
11/20
05:09 am
alvo
Alvotech and Advanz Pharma Receive Marketing Approval Across the European Economic Area for Gobivaz®, a First-in-Market Biosimilar to Simponi® (golimumab) [Yahoo! Finance]
Medium
Report
Alvotech and Advanz Pharma Receive Marketing Approval Across the European Economic Area for Gobivaz®, a First-in-Market Biosimilar to Simponi® (golimumab) [Yahoo! Finance]
11/20
04:00 am
alvo
Alvotech and Advanz Pharma Receive Marketing Approval Across the European Economic Area for Gobivaz®, a First-in-Market Biosimilar to Simponi® (golimumab)
Medium
Report
Alvotech and Advanz Pharma Receive Marketing Approval Across the European Economic Area for Gobivaz®, a First-in-Market Biosimilar to Simponi® (golimumab)
11/19
08:00 pm
alvo
ALVO Investigation: Investors Encouraged to Contact Kirby McInerney LLP
Medium
Report
ALVO Investigation: Investors Encouraged to Contact Kirby McInerney LLP
11/19
02:58 pm
alvo
Alvotech (ALVO) Faces Investor Scrutiny Amid Manufacturing Deficiencies Severely Impacting Assurances of 2025 Revenues and Adjusted EBITDA, Stock Tumbles 33% -- Hagens Berman
Low
Report
Alvotech (ALVO) Faces Investor Scrutiny Amid Manufacturing Deficiencies Severely Impacting Assurances of 2025 Revenues and Adjusted EBITDA, Stock Tumbles 33% -- Hagens Berman
11/18
02:27 pm
alvo
Alvotech (NASDAQ:ALVO) had its price target lowered by analysts at UBS Group AG from $13.00 to $10.00. They now have a "buy" rating on the stock.
Neutral
Report
Alvotech (NASDAQ:ALVO) had its price target lowered by analysts at UBS Group AG from $13.00 to $10.00. They now have a "buy" rating on the stock.
11/16
07:51 am
alvo
Alvotech (NASDAQ:ALVO) Just Reported And Analysts Have Been Lifting Their Price Targets [Yahoo! Finance]
Medium
Report
Alvotech (NASDAQ:ALVO) Just Reported And Analysts Have Been Lifting Their Price Targets [Yahoo! Finance]
11/14
01:25 pm
alvo
Alvotech (ALVO) Faces Investor Scrutiny Amid Manufacturing Deficiencies Severely Impacting Assurances of 2025 Revenues and Adjusted EBITDA, Stock Tumbles 33% -- Hagens Berman
Low
Report
Alvotech (ALVO) Faces Investor Scrutiny Amid Manufacturing Deficiencies Severely Impacting Assurances of 2025 Revenues and Adjusted EBITDA, Stock Tumbles 33% -- Hagens Berman
11/13
10:52 am
alvo
Alvotech (ALVO) Q3 2025 Earnings Call Transcript [Seeking Alpha]
Low
Report
Alvotech (ALVO) Q3 2025 Earnings Call Transcript [Seeking Alpha]
11/13
09:06 am
alvo
Alvotech (ALVO) Faces Investor Scrutiny Amid Manufacturing Deficiencies Severely Impacting Assurances of 2025 Revenues and Adjusted EBITDA, Stock Tumbles 33% -- Hagens Berman
Low
Report
Alvotech (ALVO) Faces Investor Scrutiny Amid Manufacturing Deficiencies Severely Impacting Assurances of 2025 Revenues and Adjusted EBITDA, Stock Tumbles 33% -- Hagens Berman
11/12
04:40 pm
alvo
Alvotech Reports Results for the First Nine Months of 2025 and Provides a Business Update
Low
Report
Alvotech Reports Results for the First Nine Months of 2025 and Provides a Business Update
11/12
01:26 pm
alvo
Alvotech (ALVO) Faces Investor Scrutiny Amid Manufacturing Deficiencies Severely Impacting Assurances of 2025 Revenues and Adjusted EBITDA, Stock Tumbles 33% -- Hagens Berman
Low
Report
Alvotech (ALVO) Faces Investor Scrutiny Amid Manufacturing Deficiencies Severely Impacting Assurances of 2025 Revenues and Adjusted EBITDA, Stock Tumbles 33% -- Hagens Berman
11/11
07:41 am
alvo
Alvotech (ALVO) Q3 2025 Earnings Report Preview: What To Look For [Yahoo! Finance]
Low
Report
Alvotech (ALVO) Q3 2025 Earnings Report Preview: What To Look For [Yahoo! Finance]
11/10
08:15 pm
alvo
INVESTIGATION ALERT: Edelson Lechtzin LLP Announces Investigation of Alvotech (NASDAQ: ALVO) and Encourages Investors with Substantial Losses to Contact the Firm
Low
Report
INVESTIGATION ALERT: Edelson Lechtzin LLP Announces Investigation of Alvotech (NASDAQ: ALVO) and Encourages Investors with Substantial Losses to Contact the Firm
11/10
05:28 pm
alvo
Scott+Scott Attorneys at Law LLP Reminds Investors of Its Investigation into Alvotech (NASDAQ: ALVO)
Low
Report
Scott+Scott Attorneys at Law LLP Reminds Investors of Its Investigation into Alvotech (NASDAQ: ALVO)
11/10
04:18 am
alvo
UK High Court Rules in Favor of Alvotech Paving Way for Manufacture and Market Entry of AVT06, biosimilar to Eylea® (aflibercept) [Yahoo! Finance]
Medium
Report
UK High Court Rules in Favor of Alvotech Paving Way for Manufacture and Market Entry of AVT06, biosimilar to Eylea® (aflibercept) [Yahoo! Finance]